Senescence and aging are two terms that many are not familiar with, and they come with their fair share of associated maladies. But with the recent discovery of senolytics, is it possible to halt aging in its tracks? In this joint collaboration with A*STAR, we discuss the current progress and potential of senolytics.
In this interview, we spoke to Dr Percy Luu, Founder and CEO of Incando Therapeutics to find out about his experience starting and growing a very early-stage therapeutics start-up company in Singapore.
COVID-19 has greatly affected the construction industry by causing employee absenteeism, a problem which leads to project delays and loss of revenue for many companies. Hear about how Genscript’s new SARS-CoV-2 cPass™ serology test for neutralising antibodies has been helping construction workers make informed decisions to take vaccine boosters and stay protected.
In November 2021, BCS collaborated with L.E.K. Consulting Singapore to host its 2nd case competition after the success of the 1st Singapore Life Science Case Competition in 2018.
In this article, Dr. Leung How Wing and Dr. Luan Bowu from GenScript explain important considerations for optimal recombinant antibody production.
In this interview, we spoke to Mr Kuan Chee Mun, Executive Director, and Dr. Andrea Pavesi, Consultant, to find out about AIM Biotech’s journey as a start-up, their experiences navigating the biotech industry as start-up founders, and to seek their advice for aspiring start-ups in Singapore.
What is a shareholders’ agreement, why is it important, and what does it need to contain?
Faith Sing of fsLAW demystifies the function and contents of a shareholders’ agreement, and offers tips on what you need to know when starting your new venture.
Data reproducibility as just as critical to the data itself, yet not many researchers do not know how to use metadata when analyzing their results. Singapore-based Arctoris offers an automation service that can help to make data and metadata more accessible and improve reproducibility. By Martin-Immanuel Bittner.
In this new and exciting article we capture the journey of two public-listed company – iX Biopharma and ASLAN Pharmaceuticals, listed on SGX and Nasdaq respectively in a series of questions and answers. Hear what Ms Eva Tan, Director of Corporate and Commercial Strategy at iX Biopharma and Dr. Carl Firth, founder and CEO of ASLAN Pharmaceuticals have to say about their journey going public, and how start-ups can undertake this path successfully. By Shainan Hora